<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01570140</url>
  </required_header>
  <id_info>
    <org_study_id>LSD</org_study_id>
    <nct_id>NCT01570140</nct_id>
  </id_info>
  <brief_title>Large Scale Demonstrator, Webportal Diabetes</brief_title>
  <acronym>LSD</acronym>
  <official_title>Large Scale Demonstrator, Webportal Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henk Bilo, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Isala</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical Research Foundation, The Netherlands</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: Accounting for the growth, aging and detrimental life style changes in the Dutch&#xD;
      population, the investigators expect further growth of number of known diabetes patients. The&#xD;
      economic burden with this increase will be enormous, the healthcare system is under&#xD;
      increasing pressure to provide better but more time efficient service to more people with&#xD;
      limited human resources. the investigators hypothesize that, by increasing the patients&#xD;
      self-management by offering remote care services, this reduction of the individual caseload&#xD;
      can be achieved.&#xD;
&#xD;
      Objective: Primary objective is to test the hypothesis that the consistent use of a web&#xD;
      portal and its educational content and the possibility to review personal diabetes related&#xD;
      data for type 2 diabetes patients (T2DM) in the primary care setting, will result in an&#xD;
      improvement quality of life.&#xD;
&#xD;
      Study design and methods: In this Prospective observational cohort study the investigators&#xD;
      examine the effect of the voluntarily use of a web portal and its educational content. The&#xD;
      primary end point is health related quality of life. We predefined a clinically relevant&#xD;
      difference of 0.074 in the EQ-5D index score. Secondary endpoints are diabetes-related&#xD;
      distress and well being and a selection of clinical measurements, number of contacts with&#xD;
      health care provider and the amount of prescribed medication. The participants are being&#xD;
      followed for 1-year and the data will be collected at baseline, after 6 months and 12 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2012</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Health Related Quality of Life</measure>
    <time_frame>12 months</time_frame>
    <description>EQ-5D questionnaire, representing Health Related Quality of Life dimension</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Well-being Index: WHO-5 questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>This five items questionnaire covers positive mood, vitality and general interests. The WHO-5 measures not only the absence of symptoms but gives a reliable indication of mental well-being.This includes the following dimensions:&#xD;
Good spirits&#xD;
Relaxation&#xD;
Being Active&#xD;
Waking up fresh and rested&#xD;
Being interested in things</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes-related distress</measure>
    <time_frame>12 months</time_frame>
    <description>PAID-5, questionnaire for diabetes-related distress</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing self-efficacy</measure>
    <time_frame>12 months</time_frame>
    <description>SDSCA, assessing self-efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of general practice</measure>
    <time_frame>12 months</time_frame>
    <description>Europep questionnaire, evaluation of general practice</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical parameters</measure>
    <time_frame>12 months</time_frame>
    <description>Quetelet index (BMI)&#xD;
Systolic/diastolic blood pressure&#xD;
Creatinine&#xD;
Lipid profile fasting&#xD;
Albumin/Creatinine ratio&#xD;
MDRD&#xD;
monofilament test feet&#xD;
SIMMS classification&#xD;
Fundus photo assessment&#xD;
Smoking&#xD;
Use of alcohol&#xD;
FiveShot questionnaire&#xD;
Diabetes medicine&#xD;
Antihypertensiva&#xD;
Antilipaemica&#xD;
Additional medication&#xD;
Cardiovascular complications</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">350</enrollment>
  <condition>Diabetes Mellitus Type 2</condition>
  <arm_group>
    <arm_group_label>Web portal users</arm_group_label>
    <description>T2DM patients in the primary care setting, using the web portal.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Web portal</intervention_name>
    <description>This study investigates the effects of the voluntarily use of a webportal and its educational content.</description>
    <arm_group_label>Web portal users</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study consists of people known with type 2 diabetes mellitus who are being guided and&#xD;
        treated in primary health care in the Drenthe region of the Netherlands.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A diagnosis of type 2 diabetes mellitus, as registered in the primary care system&#xD;
             under the diagnosis T90.2, and where the GP is defined as the main care giver&#xD;
&#xD;
          -  Aged 18 years or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Cohort study:&#xD;
&#xD;
          -  None&#xD;
&#xD;
        Intervention study:&#xD;
&#xD;
          -  Mental retardation or psychiatric treatment for schizophrenia, organic mental disorder&#xD;
             or bipolar disorder currently or in the past&#xD;
&#xD;
          -  Insufficient knowledge of the Dutch language to understand the requirements of the&#xD;
             study and/or the questions posed in the questionnaires&#xD;
&#xD;
          -  Life expectancy &lt; 1 year due to malignancies or other terminal illnesses&#xD;
&#xD;
          -  Cognitive impairment, including dementia, that interferes with trial participation&#xD;
&#xD;
          -  Any condition that the Investigator and/or Coordinating Investigator feels would&#xD;
             interfere with trial participation or evaluation of results&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Isala Clinics</name>
      <address>
        <city>Zwolle</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <study_first_submitted>March 29, 2012</study_first_submitted>
  <study_first_submitted_qc>April 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2012</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Medical Research Foundation, The Netherlands</investigator_affiliation>
    <investigator_full_name>Henk Bilo, MD</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

